ZELTIQ Aesthetics, Inc. to Present at the 2013 Bank of America Merrill Lynch Health Care Conference
May 06 2013 - 8:30AM
ZELTIQ® Aesthetics, Inc. (Nasdaq:ZLTQ), a medical technology
company focused on developing and commercializing products
utilizing its proprietary controlled-cooling technology platform,
today announced that Mark Foley, President and Chief Executive
Officer and Patrick F. Williams, Senior Vice President and Chief
Financial Officer, are scheduled to present at the 2013 Bank of
America Merrill Lynch Health Care Conference at Encore at the Wynn
- Las Vegas, NV.
Event: 2013 Bank of America Merrill Lynch
Health Care Conference Date: May 14, 2013
Time: 10:40 a.m. PT /1:40 p.m. ET
An audio web cast of the Company's presentation will be
available by visiting the investor relations section of ZELTIQ's
web site at www.coolsculpting.com. A replay of the presentation
will be available for 30 days.
About ZELTIQ® Aesthetics, Inc.
ZELTIQ is a medical technology company focused on developing and
commercializing products utilizing its proprietary
controlled-cooling technology platform. ZELTIQ's first commercial
product, the CoolSculpting System, is designed to selectively
reduce stubborn fat that may not respond to diet or exercise.
CoolSculpting is based on the scientific principle that fat cells
are more sensitive to cold than the overlying skin and surrounding
tissues. It utilizes patented technology of precisely controlled
cooling to reduce the temperature of fat cells in the treated area,
which is intended to cause fat cell elimination through a natural
biological process known as apoptosis. ZELTIQ developed
CoolSculpting to safely, noticeably, and measurably reduce the fat
layer.
CONTACT: Investor Relations:
Patrick F. Williams
ZELTIQ, Senior Vice President and CFO
925-474-2500
Nick Laudico
The Ruth Group
646-536-7030
nlaudico@theruthgroup.com
Zeltiq Aesthetics, Inc. (NASDAQ:ZLTQ)
Historical Stock Chart
From Jun 2024 to Jul 2024
Zeltiq Aesthetics, Inc. (NASDAQ:ZLTQ)
Historical Stock Chart
From Jul 2023 to Jul 2024